151 results
8-K
EX-10.1
QLGN
Qualigen Therapeutics Inc
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i) Material Changes; Undisclosed
8-K
EX-2.1
64icuz
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-99.1
erjp25n9km
24 Apr 23
Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
6:15am
8-K
EX-10.3
fxoa 7dho
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
hfo8 o79h3wag7kxmj
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm